Show More From the Division of Gynecologic Oncology, New York University School of Medicine, New York, NY. Leiomyosarcoma, the most frequent pure uterine sarcoma, is an aggressive tumor with a ...
Comparison of Referring and Final Pathology for Patients With Non-Hodgkin's Lymphoma in the National Comprehensive Cancer Network To evaluate morbidity, mortality, and overall and disease-free ...
Healx, an AI-powered, clinical-stage biotech company dedicated to rare diseases, today announced that the first ...
CHICAGO -- High-dose ifosfamide proved more effective at prolonging event-free survival (EFS) and overall survival (OS) than topotecan plus cyclophosphamide in relapsed/refractory Ewing sarcoma, ...
Champions Oncology (NASDAQ: CSBR) today announced that it has initiated a sponsored prospective correlative trial of patient derived xenograft modeling (PDX or Champions TumorGraft ® PDX models) in ...
The optimal negative margin required following surgical resection and perioperative radiotherapy for extremity soft tissue sarcoma (STS) remains up for debate, with investigators of a new study using ...
In this retrospective analysis, outcomes data were evaluated on patients receiving care related to extrapleural pneumonectomy for soft tissue sarcoma or bone sarcoma. “Patient selection is critical ...
Health experts have underlined that soft tissue sarcomas, a rare and complex group of cancers, require precise diagnosis, ...
A new study of adolescents and young adults (AYAs) with seven common cancers reveals that nearly one in ten patients diagnosed with non-metastatic disease later develop metastatic recurrence—a ...
Healx begins patient dosing in phase 1/2 trial to evaluate the effect of HLX-4310 on metastatic recurrence and progression in sarcomas with a focus on osteosarcoma: Cambridge, UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results